Plenary Session - inactive due to federal service
420 episodes — Page 2 of 9
CAR T causes MDS??? Manni, Goodman, Raj, Prasad
EDoes car T cause secondary AML? We discuss
Timothee and Prasad talk 2023 cancer trials
EWe talk about 2023 cancer trials
Aaron Goodman Prasad ASH UPDATES
EGoodman and I discuss ash updates. My myeloma talk https://www.youtube.com/watch?v=jAz84yCnfjQ
Mandrola and Prasad
ESubscribe to Sensible Med Pod; This is x over Post partum depression, orbita 2 and physics vs medicine
COVID19 Policy: What the US Got Wrong
EMy Lecture in Curacao 4/4 Vaccines, Masks, Mandates, Lockdowns, School closure Other lectures to come
Lecture 1 of 4 Curacao - How to Keep Up with Literature
EEntresto, Lung Transplants, How to Keep Up with Literature - Lecture to Trainees in Curacao
Advice Pre-Med Students | Lecture at UC Berkeley
EThis is a lecture I gave on November 5, 2023, to pre-medicine undergraduate students at University of California Berkeley.
Radiation oncology in GI malignancy - Nina Sanford and Bill Hall
ERadiation oncology in GI malignancy (endpoints and stratification) in the JCO
Hawai Keynote - Coffee and colon cancer & Censoring & More
EPrasad is back in Hawaii to give another keynote (good thing they cancelled Dallas not Honolulu). I discuss coffee and colon cancer, and censoring, and Lu177 PSMA
Ethics: How IRBs Can Do Better | My Denmark Lectures (Sept 2023) 3 Of 3
EThis is a lecture I gave on ethics and institutional review boards in Denmark in September 2023. It is the last of the three lectures I gave.
Prasad's lecture gets cancelled/ Cifu Gets COVID a SM crossover
EMandrola, Prasad and Cifu are back to discuss the latest drama
The State Of Immunotherapy In Oncology | My Denmark Lectures (Sept 2023) 2 Of 3
EThis is a lecture I gave on the state of immunotherapy in oncology at the Immunotherapy Symposium In Denmark in September 2023. It is the second of three lectures I gave.
Do We Have Good Evidence For New Drugs? My Denmark Lectures (Sept 2023) 1 Of 3
EThe first of the three lectures I gave in Denmark in September 2023 was on the medical evidence behind decision-making by health technology assessment groups.
Great And Crazy Things We Do In Medicine
EThis is the live recording of a talk given on the great and crazy things we do in medicine, from cancer drugs to boosters and more.
Fixing Cancer Medicine w/ Timothee Olivier
ETimothee is back to discuss Malignant and Solutions
Coumadin, ECMO, RCTs and more
EA far reaching discussion btw Mandrola and Prasad on RCTs, Coumadin, ECMO and RCTs for covid shots
Prasad and Mandrola discuss recent journal articles/ Republicans/ Stenting
ESimultaneously released on Sensible Medicine. Time to subscribe to Sensible Medicine substack and podcast.
Placebo/ Journal Errors/ Cancer Screening w/ Mandrola - SM crossover
EPlacebo/ Journal Errors/ Cancer Screening w/ Mandrola - SM crossover
Testosterone/ Should Scientists Debate/ Mike Joyner
EA sensible medicine crossover episode Follow the sensible medicine podcast feed for more of these discussions
Post Protocol Therapy - QOL - Adjuvant - Olivier Joins VP
ET. Olivier from Geneva is back. A fan favorite guest. We discuss 3 recent papers.
ADAURA OS RESULTS - THE TRIAL WAS UNETHICAL
EResearchers were too busy counting dead bodies to give the control arm appropriate therapy when their cancer recurred. Disgusting conduct. I break down ADAURA
OBS studies vs RCTs - Trial Emulation - RCT Duplicate - We debate recent JAMA Paper
EMike Putman, Todd C. Lee, John Mandrola and I debate the recent JAMA paper on RCT Duplicate. This is a spirited round table discussion on the limitations of observational data. If you are reading this, leave a comment as a review!
Myeloma Roundtable - Manni M. Raj C. VP discuss controversies
EEarly treatment of myeloma, dual vs. single maintenance, and finally transplant or no transplant.
Mammographic Screening : A complete review of the evidence
EWhy the USPSTF is wrong
The Crushing, Cruel Cost of Cancer Drugs - My Lecture
ECost of Cancer drugs - VP's lecture
Sensible Med Crossover - Cifu/ Mandrola/ Prasad & Wallensky
EI combine two latest tracks on interpreting medical studies, medical boards, 7 doses of vaccine, and finally Walensky. Stay tuned.
Cochrane Mask Debates - Jefferson/ Heneghan/ Prasad
EWe explore the fight btw NYTimes, Cochrane, and the last people keeping EBM alive
Zeb Jamrozik - Vaccine errors/ Sweden/ Equipoise & Science itself
EZeb joins me for the 7th time to discuss all the key pandemic questions
Harvard-MIT Center for Reg. Science Lecture (4-4-23) - Dubious FDA drug Approvals
EMy lecture to Harvard regulatory science
5.47 - Real World Evidence - Keynote Lecture in Denmark
EVP goes to Denmark to give the keynote at the Danish medical association conference
5.46 - What is Science: reflections on the field
EWhat is science?
5.45 - Bar Karmma - Karmma 3 | Idacel vs 'standard care
EKarmma 3 discussion; then Sensible Medicine on Long COVID, 4th year fellowships and more; Then my breakdown of FDA's NEJM Letter to the Editor
More basics on randomized controlled trials - Part 2
EI get into endpoints, surrogates, validation, blinding, crossover, and control arms.
RCT 101 And Papa Heme
EI talk RCTs 101; KM Plots; Blinding: 2:1 randomization: Concealment and more. Then Papa Heme Tells you How to Find your First Job
Tom Newman And VP Discuss Public Health
EDr. Tom Newman UCSF Emeritus Professor & Superb teacher discusses VP's recent Public Health Videos. The two don't fully agree, but the discussion is worth your time.
5.41 - Michael Putman MCW debates me on recent policy Qs
EMike Putman, asst prof. EBM Rhematologist debates me on value of boosters, observational studies and more.
Sensible Med Superbowl Plenary Session Crossover
EA new podcast feed called Sensible Medicine is up; here is a sample of what we have to offer
5.39 - Sotorasib and Codebreak 200
EI destroy the trial. Bad control arm. Informative Censoring. No OS gain. Authors DOWNPOWERED TRIAL. Fishy PFS. Fishy HRQoL. This trial should be in trash can.
Myeloma Twitter Just Makes Things Up - Lessons for All Oncologists & Expertise
EI annotate an online case discussion; Every decision is not based in evidence. Madness
5.37 - Keynote Lecture on Physician Burnout
EThis lecture on Burnout will not be like any other you have heard
5.36 - ASH UPDATE #4 - GEM CESAR
EI break down the GEM CESAR trial K, R, D, Pom, Dara, Dex, R, and Auto and all before you actually have cancer What a crazy trial!
5.35 - ASH Update #3 - the Ascent Trial
EThis uncontrolled trial of Dara-KRD claims to be looking for cure; Unfortunately, the PI has not thought through what that would look like, and accordingly all the claims are incorrect. Moreover the primary endpt is negative. Sad day for oncology
5.34 - ASH Update #2 - ALPINE - Zanibrutinib vs Ibrutinib - Deconstructed
ESample size games, primary endpoint, head to head trials in oncology Rate this podcast on itunes Coming next is Triangle trial
5.33 USC Grand Rounds Hematology
EGrand rounds on heme and heme malignancies given 12/16 at University of Southern California (some parts removed) More ASH coming soon
5.32 - ASH Update #1 - Talquetamab NEJM
EIs it acceptable to take someone with myeloma who has gotten just 2 regimens and put them on a phase 1? VP says hell no.
5.31 - MUST LISTEN Grand Rounds - COVID19 Updates
EIn this lecture given December 7, 2022, I cover 5 things: Vaccines Masking Long COVID Schools/Immunity Debt Paxlovid
5.30 Rajkumar vs Goodman; Long COVID vs Long URI
EShould we treat smoldering MM, a debate Long COVID vs Long URI Review the show; Say Hi at ASH22
5.29 Smart Start is a useless Lymphoma study
ESmart Start is a useless lymphoma study; We have to stop putting our careers ahead of patients. In the second part, I discuss the 'experts' featured on STAT. Wowzers. I will be at ask. Hit me up: [email protected]
5.28 - Pandemic Amnesty or Accountability with Paul Fenyves
EI am joined by Cornell Professor Paul Fenyves; a practicing internist Dr. Fenyves walks us through COVID19 policy. We will be back soon with more cancer medicine. Including a devastating lymphoma one.
5.27 - Multiple Myeloma - Do Our Trials Help Patients?
EI was invited to give this talk to a UK conference on Myeloma Please LEAVE A REVIEW of this podcast